DiaVacs
About:
DiaVacs is a developer of biotechnological products and drugs designed to liberate patients from lifelong insulin dependence
Website: https://www.diavacs.com
Description:
The company potentially addresses the disadvantages of prior approaches by offering local antigen-specific immunosuppression, halting the pathogenic autoimmune response without compromising the body's immune system, and complements emerging regenerative approaches by protecting newly created beta cells from autoimmune attack, enabling patients to get rid from lifelong dependency on insulin.
$850000
Edgewater, New Jersey, United States
2013-01-01
Dietrich Stephan, Haro Hartounian, Nick Giannoukakis
51-100
2015-03-11
Private
© 2025 bioDAO.ai